NEW YORK (GenomeWeb) — Adarza Biosystems said today that it has closed a $5 million Series B funding round.

The company plans to use the proceeds to expand the production capacity of its manufacturing facility in St. Peters, Missouri, and to launch its first immunoassay instrument platform. Adarza also said it will accelerate the development of assays targeting biological analytes, including cytokines, antigens, and small molecules.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.